pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,876 phase readout · 4,728 grant · 2,415 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: filing×type: approval×clear all
type
  • approval18,987
  • device 510k5,000
  • phase readout4,876
  • grant4,728
  • 8k filing2,415
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings295
  • therapy area
    • Ophthalmology5

    Week of Oct 18, 1999

    3
    ›Oct 20, 1999approval9775d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Oct 22, 1999approval9773d agoCEREZYME (IMIGLUCERASE) — FDA approvalimiglucerase

    Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION

    full page →imiglucerase →fda approvals ↗
    ›Oct 22, 1999approval9773d agoBUTORPHANOL TARTRATE PRESERVATIVE FREE (BUTORPHANOL TARTRATE) — FDA approvalBUTORPHANOL TARTRATE

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →BUTORPHANOL TARTRATE →fda approvals ↗

    Week of Oct 25, 1999

    8
    ›Oct 25, 1999approval9770d agoLABETALOL HYDROCHLORIDE — FDA approvalLABETALOL HYDROCHLORIDE

    Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

    full page →LABETALOL HYDROCHLORIDE →fda approvals ↗
    ›Oct 25, 1999approval

    Week of Nov 1, 1999

    10
    ›Nov 1, 1999approval9763d agoESTRADIOL — FDA approvalestradiol ER

    Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL

    full page →estradiol ER →fda approvals ↗
    ›Nov 1, 1999approval

    Week of Nov 8, 1999

    6
    ›Nov 8, 1999approval9756d agoCENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approvalCENESTIN

    Sponsor: ASPEN. Form: TABLET. Route: ORAL

    full page →CENESTIN →fda approvals ↗
    ›Nov 8, 1999approval

    Week of Nov 15, 1999

    8
    ›Nov 15, 1999approval9749d agoCLEOCIN HYDROCHLORIDE (CLINDAMYCIN HYDROCHLORIDE) — FDA approvalclindamycin hydrochloride

    Sponsor: PFIZER. Form: CAPSULE. Route: ORAL

    full page →clindamycin hydrochloride →fda approvals ↗
    ›Nov 16, 1999approval

    Week of Nov 22, 1999

    9
    ›Nov 22, 1999approval9742d agoTHALLOUS CHLORIDE TL 201 (THALLOUS CHLORIDE TL-201) — FDA approval

    Sponsor: CURIUM. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Nov 22, 1999approval

    Week of Nov 29, 1999

    5
    ›Nov 29, 1999approval9735d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Nov 29, 1999approval

    Week of Dec 6, 1999

    1
    ›Dec 7, 1999approval9727d agoTOPAMAX (TOPIRAMATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ← prev
    page 61 of 380
    next →
    9770d ago
    LABETALOL HYDROCHLORIDE — FDA approvalLABETALOL HYDROCHLORIDE

    Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

    full page →LABETALOL HYDROCHLORIDE →fda approvals ↗
    ›Oct 25, 1999approval9770d agoLABETALOL HYDROCHLORIDE — FDA approvalLABETALOL HYDROCHLORIDE

    Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

    full page →LABETALOL HYDROCHLORIDE →fda approvals ↗
    ›Oct 25, 1999approval9770d agoLABETALOL HYDROCHLORIDE — FDA approvalLABETALOL HYDROCHLORIDE

    Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

    full page →LABETALOL HYDROCHLORIDE →fda approvals ↗
    ›Oct 25, 1999approval9770d agoTRAZODONE HYDROCHLORIDE — FDA approvalTRAZODONE HYDROCHLORIDE

    Sponsor: APOTEX INC. Form: TABLET. Route: ORAL

    full page →TRAZODONE HYDROCHLORIDE →fda approvals ↗
    ›Oct 25, 1999approval9770d agoTRAZODONE HYDROCHLORIDE — FDA approvalTRAZODONE HYDROCHLORIDE

    Sponsor: APOTEX INC. Form: TABLET. Route: ORAL

    full page →TRAZODONE HYDROCHLORIDE →fda approvals ↗
    ›Oct 28, 1999approval9767d agoRINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: OTSUKA ICU MEDCL. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Oct 29, 1999approval9766d agoMETHYLPREDNISOLONE — FDA approvalMEDROL

    Sponsor: SANDOZ. Form: TABLET. Route: ORAL

    full page →MEDROL →fda approvals ↗
    9763d ago
    ESTRADIOL — FDA approvalestradiol ER

    Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL

    full page →estradiol ER →fda approvals ↗
    ›Nov 2, 1999approval9762d agoCENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approvalCENESTIN

    Sponsor: ASPEN. Form: TABLET. Route: ORAL

    full page →CENESTIN →fda approvals ↗
    ›Nov 2, 1999approval9762d agoPERCOCET (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: OZANTRI. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 3, 1999approval9761d agoDEXEDRINE SPANSULE (DEXTROAMPHETAMINE SULFATE) — FDA approvalMallinckrodt LLC

    Sponsor: IMPAX LABS INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Nov 3, 1999approval9761d agoZOLADEX (GOSERELIN ACETATE) — FDA approvalgoserelin LA

    Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION

    full page →goserelin LA →fda approvals ↗
    ›Nov 3, 1999approval9761d agoZOLADEX (GOSERELIN ACETATE) — FDA approvalgoserelin LA

    Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION

    full page →goserelin LA →fda approvals ↗
    ›Nov 5, 1999approval9759d agoGLIPIZIDE — FDA approvalGreenstone LLC

    Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 5, 1999approval9759d agoEPIPEN E Z PEN (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: VIATRIS. Form: INJECTABLE. Route: INTRAMUSCULAR

    full page →adrenaline →fda approvals ↗
    ›Nov 5, 1999approval9759d agoFLAREX (FLUOROMETHOLONE ACETATE) — FDA approvalHARROW, INC.

    Sponsor: HARROW EYE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC

    full page →fda approvals ↗
    9756d ago
    DOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Nov 8, 1999approval9756d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Nov 8, 1999approval9756d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Nov 10, 1999approval9754d agoGLIPIZIDE — FDA approvalGreenstone LLC

    Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 12, 1999approval9752d agoCENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approvalCENESTIN

    Sponsor: ASPEN. Form: TABLET. Route: ORAL

    full page →CENESTIN →fda approvals ↗
    9748d ago
    ISOVUE-250 (IOPAMIDOL) — FDA approval

    Sponsor: BRACCO. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Nov 17, 1999approval9747d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →METHADONE HYDROCHLORIDE →fda approvals ↗
    ›Nov 17, 1999approval9747d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →METHADONE HYDROCHLORIDE →fda approvals ↗
    ›Nov 18, 1999approval9746d agoDIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (ATROPINE SULFATE) — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 18, 1999approval9746d agoDIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (ATROPINE SULFATE) — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 18, 1999approval9746d agoDIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (ATROPINE SULFATE) — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 19, 1999approval9745d agoHEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (HEPARIN SODIUM) — FDA approvalHEPARIN SODIUM

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →HEPARIN SODIUM →fda approvals ↗
    9742d ago
    LUPRON (LEUPROLIDE ACETATE) — FDA approvalInvaGen Pharmaceuticals Inc

    Sponsor: ABBVIE ENDOCRINE INC. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Nov 23, 1999approval9741d agoULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approvalremifentanil hydrochloride

    Sponsor: MYLAN INSTITUTIONAL. Form: INJECTABLE. Route: INJECTION

    full page →remifentanil hydrochloride →fda approvals ↗
    ›Nov 24, 1999approval9740d agoFOSAMAX (ALENDRONATE SODIUM) — FDA approvalALENDRONATE SODIUM

    Sponsor: ORGANON. Form: TABLET. Route: ORAL

    full page →ALENDRONATE SODIUM →fda approvals ↗
    ›Nov 24, 1999approval9740d agoFOSAMAX (ALENDRONATE SODIUM) — FDA approvalALENDRONATE SODIUM

    Sponsor: ORGANON. Form: TABLET. Route: ORAL

    full page →ALENDRONATE SODIUM →fda approvals ↗
    ›Nov 24, 1999approval9740d agoDILAUDID (HYDROMORPHONE HYDROCHLORIDE) — FDA approvalSpecGx LLC

    Sponsor: RHODES PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Nov 24, 1999approval9740d agoLACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approvalCALCIUM CHLORIDE 10%

    Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION

    full page →CALCIUM CHLORIDE 10% →fda approvals ↗
    ›Nov 24, 1999approval9740d agoLACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approvalCALCIUM CHLORIDE 10%

    Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION

    full page →CALCIUM CHLORIDE 10% →fda approvals ↗
    ›Nov 24, 1999approval9740d agoPOTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approvalCALCIUM CHLORIDE 10%

    Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION

    full page →CALCIUM CHLORIDE 10% →fda approvals ↗
    9735d ago
    BUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Dec 1, 1999approval9733d agoMEDROL (METHYLPREDNISOLONE) — FDA approvalMEDROL

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →MEDROL →fda approvals ↗
    ›Dec 2, 1999approval9732d agoDYNACIN (MINOCYCLINE HYDROCHLORIDE) — FDA approvalMINOCYCLINE HYDROCHLORIDE

    Sponsor: ALVOGEN. Form: CAPSULE. Route: ORAL

    full page →MINOCYCLINE HYDROCHLORIDE →fda approvals ↗
    ›Dec 2, 1999approval9732d agoDYNACIN (MINOCYCLINE HYDROCHLORIDE) — FDA approvalMINOCYCLINE HYDROCHLORIDE

    Sponsor: ALVOGEN. Form: CAPSULE. Route: ORAL

    full page →MINOCYCLINE HYDROCHLORIDE →fda approvals ↗
    $ASPU0.2893-0.26%
    $PFE24.54-0.16%
    $ASPU0.2893-0.26%
    $VTRS17.24-0.23%
    $HROW38.45-8.19%
    $AMRX17.92-0.28%
    $IGC0.2670+0.41%
    $PYPD3.9000-8.02%
    $PYPD3.9000-8.02%
    $ANIP77.65-1.12%
    $ANIP77.65-1.12%
    $ANIP77.65-1.12%
    $OGN13.52-0.29%
    $OGN13.52-0.29%
    $PFE24.54-0.16%
    $ASPU0.2893-0.26%